CMI vs PSIX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

CMI

52.8
AI Score
VS
PSIX Wins

PSIX

56.8
AI Score

Investment Advisor Scores

CMI

53score
Recommendation
BUY

PSIX

57score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CMI PSIX Winner
Forward P/E 13.5685 32.6797 CMI
PEG Ratio 0.9319 0.8222 PSIX
Revenue Growth 13.5% -0.9% CMI
Earnings Growth 113.7% 8.2% CMI
Tradestie Score 52.8/100 56.8/100 PSIX
Profit Margin 9.3% 10.4% PSIX
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

CMI 1M: -12.5% · 3M: -27.1% PSIX 1M: -13.7% · 3M: -0.8%

Current Technical Phase

CMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 34

RSI (14): 33.9 · Price: $460.29

PSIX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.5 · Price: $40.21

Fundamentals Snapshot

Metric CMI PSIX
Market Cap — —
Forward P/E 13.8 12.2
Trailing P/E 18.9 12.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.2%
EPS 23.97 2.95
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, PSIX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.